Generic Drug Analysis & Statistics, January 2013 (p20)

24/7 Customer Support

Talk to Shadi

+1 718 514 2762

All regions

571-610 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Southeast Asian Pharmaceuticals Industry: Generic Drug Market

Southeast Asian Pharmaceuticals Industry: Generic Drug Market

  • $ 10 000
  • Industry report
  • September 2010
  • by Frost & Sullivan

This Market Engineering research service has been developed to address the generics drug market in Southeast Asia that includes Malaysia, Philippines, Singapore and Thailand. This research service presents ...

  • Industries : Generic Drug
  • Countries : Philippines, Singapore, Asia, Thailand, Malaysia
Healthcare Industry Overview in Ethiopia

Healthcare Industry Overview in Ethiopia

  • $ 7 500
  • Industry report
  • July 2010
  • by Frost & Sullivan

Healthcare Industry Overview in Ethiopia provides an overview of the healthcare system in Ethiopia as well as a brief overview of the pharmaceutical industry. In terms of the healthcare environment, the ...

  • Industries : Generic Drug, Healthcare
  • Countries : Ethiopia
  Fipronil Survey  in China

Fipronil Survey in China

  • $ 11 917
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Export Analysis of Fipronil in China

Export Analysis of Fipronil in China

  • $ 1 609
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Fipronil Technology in China

Fipronil Technology in China

  • $ 804
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Forecast of Fipronil in China

Forecast of Fipronil in China

  • $ 804
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Influential factors of Fipronil industry in China

Influential factors of Fipronil industry in China

  • $ 1 287
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Production and Consumption of Fipronil in China

Production and Consumption of Fipronil in China

  • $ 1 287
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
  Fipronil Survey  in China

Fipronil Survey in China

  • $ 11 917
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets

The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets

  • $ 3 500
  • Industry report
  • May 2010
  • by GBI Research

The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets Summary GBI Research's report, ?The Future of Ophthalmology Therapeutics, ...

  • Industries : Therapy, Generic Drug, Drug Discovery and Development
  • Countries : World
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry

Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry

  • $ 300
  • Industry report
  • May 2010
  • by Aruvian's R'search

A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use. Generic drugs are less expensive because generic manufacturers ...

  • Industries : Generic Drug
  • Countries : United States
German Pharma Sector Analysis

German Pharma Sector Analysis

  • $ 600
  • Industry report
  • April 2010
  • by RNCOS

Germany is one of the largest pharmaceutical markets in the world. Most of the pharma companies in Germany are focused on research, which has led the country to become one of the most advanced pharma markets ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : Germany
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010

Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010

  • $ 1 681
  • Industry report
  • March 2010
  • by Espicom Business Intelligence

With high-profile inhalable drugs coming off patent, the prospects for the generic sector should be good - but only if companies can overcome production, regulatory and litigation hurdles. The inhalation ...

  • Industries : Drug and Medication, Generic Drug
  • Countries : United States
Strategic Alliances: Synergistic Path To Value Creation

Strategic Alliances: Synergistic Path To Value Creation

  • $ 2 995
  • Industry report
  • January 2010
  • by CHI Insight Pharma Reports

As the first decade of the 21st century comes to an end, the pharmaceutical industry is facing a major revenue downturn. The contributing factors are the expiration of patents on a number of blockbuste ...

  • Industries : Generic Drug, Pharmaceutical
The Future of  Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

The Future of  Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

  • $ 3 500
  • Industry report
  • December 2009
  • by GBI Research

Summary The author has released its latest research ?The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways?. The report provides insights on the biosimilars ...

  • Industries : Generic Drug
  • Countries : World, Europe, United States, Japan
Barr Pharmaceuticals Generics Company Intelligence Report

Barr Pharmaceuticals Generics Company Intelligence Report

  • $ 331
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Barr Pharmaceuticals is one of the USA's leading generic manufacturers. The company has a policy of early market entry for generics, and as such is generally involved in a large amount of litigation. ...

  • Industries : General Medicine and Specialty Medicine, Generic Drug
Pliva Generics Company Intelligence Report

Pliva Generics Company Intelligence Report

  • $ 331
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Pliva is based in Croatia, and is one of that country's leading manufacturing companies. It is also one of the largest pharmaceutical manufacturers in central Europe. It was privatised in the mid 1990s. ...

  • Industries : Generic Drug
  • Countries : United States
Zentiva Generics Company Intelligence Report

Zentiva Generics Company Intelligence Report

  • $ 331
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Zentiva was created through the merger of the Czech company, Léciva, and the Slovak firm Slovakofarma, which was completed in August 2003. The two former companies began selling products under the Zentiva ...

  • Industries : Generic Drug
  • Countries : Turkey, Slovakia (slovak Republic), Czech Republic, Europe, Lithuania, Ukraine, Russian Federation, Romania, Poland, Latvia, Bulgaria, World
Japanese Pharmaceutical Market, 2009-2024

Japanese Pharmaceutical Market, 2009-2024

  • $ 2 330
  • Industry report
  • October 2009
  • by Visiongain

Report Details How will the world's second-largest pharma market shape up in the future? What effects will policy shifts and an increasing move to generics have? Our new report explains. Japan is the second-largest ...

  • Industries : Generic Drug
  • Countries : Japan
The Pharmaceutical Industry in Botswana

The Pharmaceutical Industry in Botswana

  • $ 7 500
  • Industry report
  • September 2009
  • by Frost & Sullivan

This research service presents an in-depth analysis of the Botswana pharmaceutical industry. It provides a general insight into processes of regulations, medical insurance, healthcare procurement and financing. ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : Botswana
World Generics Market 2009-2024

World Generics Market 2009-2024

  • $ 2 330
  • Industry report
  • August 2009
  • by Visiongain

Impending patent expiries, increasing competition and changes in legislation: where will generics go from 2009 onwards? Our new report - World Generics Market 2009-2024 - explains the opportunities and ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : World
Emerging Opportunities in Controlled-Release Generic Drugs

Emerging Opportunities in Controlled-Release Generic Drugs

  • $ 1 681
  • Industry report
  • August 2009
  • by Espicom Business Intelligence

From emerging specialist companies to established generic producers, alternative drug delivery technologies are increasingly being seen as a route to a competitive edge in the generics industry. While ...

  • Industries : Generic Drug, Drug Delivery Technology
  • Countries : United States
The Survey of Fipronil in China

The Survey of Fipronil in China

  • $ 9 683
  • Industry report
  • May 2009
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, fipronil industry development will be largely restricted as Chinese government released the regulation ...

  • Industries : Generic Drug
  • Countries : China
World Generic Market Report 2009

World Generic Market Report 2009

  • $ 1 220
  • Industry report
  • January 2009
  • by Espicom Business Intelligence

This new 2 volume, 714-page edition is packed with facts, figures, analysis and statistics, that provides the most thorough analysis available on generic markets, products and companies and the issues ...

  • Industries : Drug and Medication, Generic Drug
  • Countries : World
World Generics Market, 2008-2013

World Generics Market, 2008-2013

  • $ 2 330
  • Industry report
  • November 2008
  • by Visiongain

The generics market remains a major growth area in the global healthcare market. That growth has been partly driven by cost-containment in several national healthcare sectors, with governments seeking ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : World
Biosimilars: A viable market - but when?

Biosimilars: A viable market - but when?

  • $ 2 657
  • Industry report
  • September 2008
  • by Espicom Business Intelligence

Providing? A thorough review of the latest regulatory situation in the USA, Europe and selected markets An examination of products that are currently available for development: - EPO - HGH - G-CSF ...

  • Industries : Generic Drug, Biotechnology
  • Countries : United States, France, Europe, Netherlands
All Change in the US Pharma Market?

All Change in the US Pharma Market?

  • $ 1 681
  • Industry report
  • June 2008
  • by Espicom Business Intelligence

The rise of generics, products at risk and defence strategies The figures speak for themselves. Of the 150 products detailed in this report, 24 faced generic competition in 2006. This rose to 35 in 2007 ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : United States
CNS Generic Drugs: Prospects and Opportunities to 2012

CNS Generic Drugs: Prospects and Opportunities to 2012

  • $ 1 681
  • Industry report
  • April 2008
  • by Espicom Business Intelligence

One of the fastest growing drug sectors in terms of product and market value, CNS presents the generics industry with much needed on-going product opportunities ANTIDEPRESSANTS Antidepressant sales in ...

  • Industries : Generic Drug
  • Countries : United States, World
Opportunities and Challenges for Generic Drugs in Australia

Opportunities and Challenges for Generic Drugs in Australia

  • $ 837
  • Industry report
  • March 2008
  • by Espicom Business Intelligence

Valued at US$1.43 billion, the Australian generics market accounts for 14.9% of the total pharma market value but only 30% by volume. With the government keen to keep drug costs down, and with a numbe ...

  • Industries : Generic Drug
  • Countries : Australia
Generics League  - Market Analysis and Forecasts, 2007-2012, 2017 &2022

Generics League - Market Analysis and Forecasts, 2007-2012, 2017 &2022

  • $ 2 330
  • Industry report
  • February 2008
  • by Visiongain

The generic industry is a fast evolving market; with significant lucrative opportunities. The generic market is structurally set to experience high growth potential. That wave is partly driven by cost-containment ...

  • Industries : Generic Drug, Pharmaceutical
About 400 reports

Download Unlimited Documents from Trusted Public Sources

Biosimilars Market Forecast in Europe

  • After Generics It's the Turn of Biosimilars, a Budding Market
  • September 2014
    2 pages
  • Biosimilars  

    Drug  

  • Europe  

    Spain  

    World  

View report >

8 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Mylan Inc.

United States

Teva Pharmaceuticals

United States

Bayer AG

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.